Search

Insulin Pump Start-Up Training

66
Considerations for getting patients started on new insulin pumps.

Content Developed By: Katherine Krieder Evans and Dana Roseman

Tool Created and Reviewed by: ADCES Tech Committee and the danatech staff

Prescriber Sign-Off for Insulin Pump Start-Up Training

Insulin pump start-up education (“pump training”) takes 1-3 hours and should be done in an outpatient setting, such as the prescriber/specialist’s office. Pump manufacturers employ or contract with health care professionals (RDs, RNs and PharmDs) who are usually CDCES certified by the pump manufacturer as a certified pump trainer (CPT). CPTs provide pump training services, following the prescribing physician’s pump start orders.

The prescriber is responsible for providing/signing off on pump start orders to the diabetes care and education specialist or designated pump trainer assigned to provide the pump start-up training.

These include:

  • Starting basal rate(s)
  • Insulin-to-carbohydrate ratio(s) (ICR)
  • Target blood glucose level(s)10,11
  • Correction (or sensitivity) factor(s) and instructions for use
  • Duration of insulin action (“insulin on board” or “active insulin time”)
  • Self-monitoring of blood glucose (SMBG) instructions or utilization of a CGM device
  • Communication guidelines, i.e., who, when and where the patient contacts for reporting glucose results, asking for diabetes management assistance (specialist/prescriber) and asking for technical assistance (pump manufacturer/CDCES)
  • Understand how to upload the device and provide data to the provider/CDCES
  • Determine who is available 24/7 to cover medical management questions that may arise.4

The specialist should carefully set the pump startup date, assuring that the individual’s first few weeks of pump therapy are planned during “normal routine” days, avoiding situations or conditions that may adversely affect blood glucose levels or interfere with the establishment of basal rates.9

Start-up orders should be provided to the individual several days in advance and should include:

  • 24-48 hour pre-pump adjustments in insulin injection therapy
  • Glucose history either through meter or CGM data upload
  • A list of supplies to bring to the pump start-up appointment
  • Specific information regarding appointment time and location9

The pump wearer must also learn the technical components of their pump, including how to:

  • Insert or charge the battery
  • Fill and insert the insulin cartridge/reservoir
  • Insert and change the infusion set and tubing (if applicable)
  • Input information for the pump to calculate appropriate insulin dosages
  • Program basal rate changes
  • Review the pump history. With advances in sensor-integrated insulin pumps, a thorough understanding of the automated systems and the potential to revert to manual mode is needed. Most manufacturers require that training on their pump is conducted by a health care provider certified by the manufacturer as a pump trainer (“CPT”). A pump start is best conducted at a time in the day and on the day(s) of the week when the managing health care professional is available for medical management following the pump initiation.

For traditional (non-AID) insulin pump therapy, users may need to manually enter glucose values—typically from SMBG or CGM—when calculating bolus doses. In automated insulin delivery (AID) systems, glucose data from a compatible CGM is transmitted directly to the pump algorithm, which automatically incorporates these readings to adjust insulin delivery without requiring manual glucose entry by the user. 

Specific instructions for follow-up and management during the first few weeks after pump start-up should include: Frequent SMBG, i.e. minimum of four to five times per day, i.e. 3:00 a.m., fasting, before each meal, 2 hours after meals and bedtime.

  • Limiting alcohol and high-fat foods
  • Inputting all carbohydrate values
  • Recording any additional insulin or carbohydrate intake outside of the dosing within the insulin pump (correctional factors for blocked cannula, carbohydrates for hypoglycemia) that would not otherwise be noted in the pump download
  • Recording any unexpected or unusual events that could affect blood glucose levels, e.g., stress or illness, unusual exercise routine as well as the onset of menses
  • Instructions to upload or e-mail the information to the diabetes care and education specialist as agreed upon, generally initially daily
  • Reminders to call the pump manufacturer’s support service with questions or problems related to the technical functions of the pump if the diabetes care and education specialist is not available

Follow Up

A follow-up visit should occur within one week after start-up. This allows for the opportunity to review and observe an infusion set or pod site change, remove pump syringe/cartridge, filling and insertion. The individual should be in contact with the prescriber or CDCES/CPT within 2-4 weeks after the pump start-up for a review of insulin pump download data including glucose, dosing, compliance with infusion site changes, alarms and any overriding of the automated system. Review of infusion set sights and options should also occur.

Non-programmable insulin patch pumps are also available. These systems have a fixed basal rate (different rates available) along with an option for bolus delivery. The dosing is not integrated into the pump but is at the discrepancy of the wearer. Data from these pumps is not downloadable at this time.

View more pump training documents

 

References

Grouped by the claim each source supports. Primary and official sources — ADA, FDA, danatech, peer-reviewed — are tagged and listed first within each group. Compiled and verified July 2026.

2026 ADA Standards of Care & AID as preferred delivery
  1. 1. American Diabetes Association. 7. Diabetes Technology: Standards of Care in Diabetes—2026. Diabetes Care. 2026;49(Suppl 1):S150–S178. AID is the standard of care and preferred delivery method for people with type 1 diabetes who can safely use the device; rec. 7.27 supports open-source AID management advice.Primary
  2. 2. American Diabetes Association. ADA Releases "Standards of Care in Diabetes—2026." Press release, Dec 2025. Confirms new guidance removing prior treatment prerequisites before initiating CSII or AID.Primary
  3. 3. CGM: ADA 2026 Standards of Care. American Academy of Family Physicians. Documents Rec. 7.8a — no requirement for C-peptide, islet autoantibodies or insulin-treatment duration before CSII or AID.
What integration is — and why not every integrated pump is AID
  1. 4. Boughton CK, Hovorka R. Automated insulin delivery in adults. Review describing sensor-augmented pump therapy and low-glucose suspend / predictive low-glucose management as distinct from full AID.
  2. 5. Sensor-Augmented Insulin Pumps and Hypoglycemia Prevention in Type 1 Diabetes. Describes SAP with and without automated insulin suspension — the integration-without-full-AID category the page distinguishes.
  3. 6. Closed-Loop Insulin Delivery Versus Sensor-Augmented Pump Therapy in Older Adults With Type 1 Diabetes (ORACL). Diabetes Care. 2022;45(2):381. Contrasts closed-loop AID against SAP in "manual mode" with optional low-glucose suspend.
Meal input differs by system (including the iLet)
  1. 7. U.S. Food and Drug Administration. FDA Clears New Insulin Pump and Algorithm-Based Software (iLet). Confirms the iLet replaces conventional carb counting with a meal-announcement feature and initializes on body weight alone.Primary
  2. 8. danatech / ADCES. FDA Approves iLet Bionic Pancreas. danatech's own coverage of the meal-announcement mechanism.danatech
  3. 9. Beta Bionics. Meal Announcements Guide for iLet Bionic Pancreas. Manufacturer instruction: announce the meal when eating begins, not before; do not announce if more than 30 minutes have passed; do not use to correct highs.Manufacturer
Correction behavior, bolus workflow & insulin stacking
  1. 10. American Diabetes Association. 7. Diabetes Technology: Standards of Care in Diabetes—2026. (See ref. 1.) Supports individualized device selection and system-specific use rather than a single correction rule.Primary
  2. 11. Beta Bionics. Meal Announcements Guide for iLet Bionic Pancreas. (See ref. 9.) Instruction not to use meal announcements to correct a high, illustrating why correction workflow is system-specific.Manufacturer
CGM data gaps, questionable readings & confirming with a meter
  1. 12. diaTribe. Your Guide to the 2026 ADA Standards of Care. Summarizes the Standards' guidance to use a glucometer when CGM readings don't match symptoms, e.g. during warm-up periods.
  2. 13. American Diabetes Association. 7. Diabetes Technology: Standards of Care in Diabetes—2026. (See ref. 1.) Underlying recommendation for confirmatory glucose-meter use.Primary
Insulin-delivery failure: AID cannot confirm insulin is reaching the body
  1. 14. danatech / ADCES. Troubleshooting Unexplained Hyperglycemia. danatech's own step-by-step guidance: mechanical, behavioral and metabolic causes of unexplained highs; when to check ketones; when to seek emergency care for DKA.danatech
  2. 15. Howsmon DP, et al. Early Detection of Infusion Set Failure During Insulin Pump Therapy in Type 1 Diabetes. Confirms infusion-set failure can cause prolonged hyperglycemia or DKA, characterized by rising glucose despite increased insulin infusion.
  3. 16. Frequent Insulin Infusion Site Failures "a Huge Problem." Medscape, Mar 2026. Reports that a large share of AID users experience infusion-site failures; unexplained hyperglycemia can serve as a clinical proxy for undetected occlusion.

Primary = official ADA, FDA, danatech or peer-reviewed source. Manufacturer = manufacturer product or labeling page.

All URLs verified accessible July 2026. Device insulin clearances and indications should be confirmed against the current IFU. The page defers current-device specifics to Find & Compare, so no device-model citations are listed here.


The Danatech Digest

Join 25,000+ professionals who get our latest diabetes technology updates

DISCLAIMERS:

This site and its services do not constitute the practice of medical advice, diagnosis or treatment. Always talk to your diabetes care and education specialist or health care provider for diagnosis and treatment, including your specific medical needs. If you have or suspect that you have a medical problem or condition, please contact a qualified health care professional immediately. To find a diabetes care and education specialist near you, visit the ADCES finder tool.

ADCES and danatech curate product specifics and periodically review them for accuracy and relevance. As a result, the information may or may not be the most recent. We recommend visiting the manufacturer's website for the latest details if you have any questions.


danatech is Made Possible by Grant Funding and Industry Sponsorship